Tasuku Honjo
MD, PhD
Distinguished Professor; Nobel Laureate
👥Biography 个人简介
Tasuku Honjo is a Nobel Prize laureate (2018) who discovered PD-1 (programmed death-1) and demonstrated its role as a key checkpoint in suppressing immune responses, including anti-tumor immunity. His laboratory's work showing that PD-1 blockade could treat cancer established the scientific foundation for pembrolizumab, nivolumab, and the entire class of anti-PD-1/PD-L1 therapies now transforming oncology across virtually every cancer type.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Tasuku Honjo 的研究动态
Follow Tasuku Honjo's research updates
留下邮箱，当我们发布与 Tasuku Honjo（Kyoto University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment